首页> 美国卫生研究院文献>Mayo Clinic Proceedings >Antiepileptic Drugs 2012: Recent Advances and Trends
【2h】

Antiepileptic Drugs 2012: Recent Advances and Trends

机译:抗癫痫药2012:最新进展和趋势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the United States by the Food and Drug Administration. A literature search was conducted using PubMed, MEDLINE, and Google for all English-language articles that discuss newly approved AEDs and the use of AEDs in epilepsy in the United States from January 1, 2008, through December 31, 2011. Five new agents were identified that have come onto the market within the past 2 years. Moreover, 3 trends involving AEDs have become clinically important and must be considered by all who treat patients with epilepsy. These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. This article discusses the most recent AEDs approved for use in the United States and the 3 important trends shaping the modern medical management of epilepsy.
机译:现在,美国食品和药物管理局批准了24种抗癫痫药(AED)用于癫痫病的治疗。从2008年1月1日至2011年12月31日,使用PubMed,MEDLINE和Google进行了文献搜索,讨论了所有英语文章,这些文章讨论了新批准的AED以及在美国癫痫中使用AED的情况。确定在过去2年内已投放市场。此外,涉及AED的3种趋势在临床上已经变得很重要,所有治疗癫痫患者的患者都必须考虑。这些趋势包括AED的通用替代问题,预测某些种族人群中严重不良事件的药物基因组学以及涉及整个AED类别的自杀风险问题。本文讨论了最近批准在美国使用的AED,以及塑造癫痫现代医学管理的3个重要趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号